Loading…
Perrigo Company plc is projected to rise to $10.85 by 2027, a +7% move from its current price of $10.11. PRGO is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $9.88 | $10.12 | $10.36 | +0.05% |
| Aug 3 | $9.79 | $10.12 | $10.46 | +0.11% |
| Aug 4 | $9.72 | $10.13 | $10.55 | +0.16% |
| Aug 5 | $9.67 | $10.13 | $10.62 | +0.21% |
| Aug 6 | $9.62 | $10.14 | $10.68 | +0.26% |
| Aug 7 | $9.57 | $10.14 | $10.74 | +0.32% |
| Aug 8 | $9.54 | $10.15 | $10.80 | +0.37% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $9.54 | $10.15 | $10.80 | +0.37% |
| Week 2 | $9.33 | $10.19 | $11.12 | +0.74% |
| Week 3 | $9.18 | $10.22 | $11.39 | +1.12% |
| Week 4 | $9.06 | $10.26 | $11.62 | +1.49% |
| Week 5 | $8.96 | $10.30 | $11.84 | +1.87% |
| Week 6 | $8.88 | $10.34 | $12.04 | +2.25% |
| Week 7 | $8.80 | $10.38 | $12.23 | +2.63% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands.
The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013.
Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Perrigo Company plc (PRGO) is a healthcare company in the Consumer Self-Care space, with a global footprint and a broad OTC portfolio. The stock trades at $10.10 per share and has a market capitalization of $1.4B, ranking 2245. The current price sits near a long-standing range, with a forecast that envisions gradual upside through 2030 and significant long-term gains by 2050.
The forecast highlights a path from near-term stability to stronger growth in later years, with notable 2031 through 2050 upside and high potential ROI ranges.
A major floor 15.3% below — a decisive break under it would weaken the trend.
The nearest floor, 6.1% below — buyers have tended to step in here.
The nearest ceiling, 10.7% above — a clean break opens room to run.
A major ceiling 21.3% above — clearing it would confirm fresh momentum.
Key PRGO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PRGO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $10.26 | Sell | $10.25 | Sell |
| MA 10 | $10.30 | Sell | $10.29 | Sell |
| MA 20 | $10.43 | Sell | $10.36 | Sell |
| MA 50 | $10.56 | Sell | $10.58 | Sell |
| MA 100 | $10.68 | Sell | $11.28 | Sell |
| MA 200 | $12.86 | Sell | $13.53 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 44.89 | Neutral |
| Stoch RSI (14) | 22.89 | Neutral |
| CCI (20) | -75.56 | Neutral |
| Williams %R (14) | -83.33 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -0.39 | Sell |
| Bollinger %B (20,2) | 0.28 | Neutral |
| Stochastic %K (14) | 16.67 | Buy |
| TRIX (15) | -0.09 | Sell |
| Awesome (5,34) | -0.08 | Sell |
| Ultimate (7,14,28) | 40.42 | Neutral |
| Momentum (10) | -0.61 | Sell |
| Aroon Osc (25) | 28.00 | Buy |
| Hull MA (9) | 10.30 | Sell |
| ADX (14) | 8.95 | Neutral |
| ATR (14) | 0.22 | Info |
The 30-day technical picture is neutral. The RSI14 is 40, and the near-term trend shows mixed momentum. The 50-day moving average is $10.62 and the 200-day moving average is $13.20, signaling a nuanced balance between support and momentum.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $9.25 | $10.11 | $12.77 | 0% | Neutral | |
| $8.76 | $10.85 | $14.14 | +7% | Neutral | |
| $9.11 | $11.55 | $15.55 | +14% | Neutral | |
| $9.51 | $12.31 | $17.00 | +22% | Bullish | |
| $9.62 | $12.66 | $17.88 | +25% | Bullish | |
| $10.91 | $14.58 | $20.98 | +44% | Bullish | |
| $12.55 | $17.03 | $24.92 | +68% | Bullish | |
| $13.59 | $18.69 | $27.78 | +85% | Bullish | |
| $14.30 | $19.92 | $30.03 | +97% | Bullish | |
| $13.76 | $19.40 | $29.64 | +92% | Bullish | |
| $20.85 | $31.08 | $50.20 | +207% | Bullish | |
| $31.19 | $51.06 | $89.46 | +405% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $9.25 | $10.11 | $12.08 | +0.00% |
| September 2026 | $8.74 | $10.30 | $12.45 | +1.84% |
| October 2026 | $8.95 | $10.61 | $12.94 | +3.05% |
| November 2026 | $8.85 | $10.54 | $12.95 | -0.69% |
| December 2026 | $8.63 | $10.32 | $12.77 | -2.06% |
Click any year to see its month-by-month PRGO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, PRGO is projected to trade between $9.25 and $12.77, averaging $10.11 — a potential gain of 0% from today's $10.11. A consolidation phase looks the most probable path here.
Perrigo Company plc's 2027 outlook centres on $10.85, within a $8.76 to $14.14 range. That is up +7% on the projected 2026 average. That marks a +7% change versus current levels. Price action looks broadly range-bound.
By 2028, PRGO could reach as high as $15.55, with a base case around $11.55 and support toward $9.11 — roughly +14% from $10.11. A consolidation phase looks the most probable path here.
Expect PRGO to range from $9.51 to $17.00 through 2029. The $12.31 average target implies a +22% move from current prices. That is up +7% on the projected 2028 average. Momentum favours further upside here.
The PRGO price prediction for 2030 points to an average of $12.66 (low $9.62, high $17.88) — a potential gain of +25% on today's $10.11. Buyers look set to stay in control over this stretch.
In 2031, PRGO is projected to trade between $10.91 and $20.98, averaging $14.58 — a potential gain of +44% from today's $10.11. That is up +15% on the projected 2030 average. Momentum favours further upside here.
Perrigo Company plc's 2032 outlook centres on $17.03, within a $12.55 to $24.92 range. That is up +17% on the projected 2031 average. That marks a +68% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, PRGO could reach as high as $27.78, with a base case around $18.69 and support toward $13.59 — roughly +85% from $10.11. Momentum favours further upside here.
Expect PRGO to range from $14.30 to $30.03 through 2034. The $19.92 average target implies a +97% move from current prices. That is up +7% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The PRGO price prediction for 2035 points to an average of $19.40 (low $13.76, high $29.64) — a potential gain of +92% on today's $10.11. Momentum favours further upside here.
In 2040, PRGO is projected to trade between $20.85 and $50.20, averaging $31.08 — a potential gain of +207% from today's $10.11. That is up +60% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Perrigo Company plc's 2050 outlook centres on $51.06, within a $31.19 to $89.46 range. That is up +64% on the projected 2040 average. That marks a +405% change versus current levels. Momentum favours further upside here.
Investing $1,000 in PRGO today (≈ 98.911968 PRGO) could be worth
$5,050
+$4,050 (+405%) by 2050 · US Dollar
Based on the average projected PRGO price of $51.06 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PRGOwould be worth at today's price.
$1,000 invested in PRGO on Jul 31, 2025 (≈ 37.495313 PRGO) would be worth
$379.08
-$620.92 (-62.1%) today · 0.38× · US Dollar
Based on a PRGO entry price of $26.67 vs. today's $10.11.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $10.09 | $1,001.98 | +0.2% |
| 1 month ago | $10.31 | $980.6 | -1.9% |
| 3 months ago | $11.92 | $848.15 | -15.2% |
| 6 months ago | $14.32 | $706.01 | -29.4% |
| 1 year ago | $26.67 | $379.08 | -62.1% |
| All time (5.0y) ago | $48.33 | $209.19 | -79.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PRGO forecast.
Our base-case forecast reaches $20.00 around 2040.
Implied market cap at $20.00: $2.77B
The multi-year forecast shows an upward trajectory with rising averages and strong longer‑term upside. In 2026 the min is $9.25, the avg is $10.10, and the max is $12.88, with a 0% ROI and neutral sentiment. By 2027 the avg rises to $10.89 (ROI 7.8%), and by 2028 to $11.39 (ROI 12.8%), with ongoing neutral sentiment.
The 2029–2035 period shifts to bullish, with 2029 avg $12.23 (ROI 21.1%), 2030 avg $12.56 (ROI 24.3%), 2031 avg $14.50 (ROI 43.5%), 2032 avg $17.41 (ROI 72.4%), 2033 avg $19.09 (ROI 89%), 2034 avg $20.02 (ROI 98.2%), and 2035 avg $19.53 (ROI 93.3%). The outlook strengthens further into 2040 (avg $31.86, ROI 215.5%) and 2050 (avg $51.61, ROI 411%), both labeled BULLISH. Investors should note these are estimates, not guarantees, and carry inherent uncertainty.
Tap a question to reveal the answer.
In 2030 the forecast shows an avg price of $12.56, with a min of $9.31 and a max of $18.26; the ROI is 24.3% and sentiment is BULLISH.
The long‑term forecast turns bullish from 2029 onward, with rising averages and ROIs (e.g., 43.5% in 2031, 215.5% in 2040, 411% in 2050). These are estimates and not guarantees.
Yes. The 2050 forecast lists an avg of $51.61 and a max of $95.44, so a price around $50 is within the long‑term forecast range.
Current price is $10.10, and the 30‑day range is $8.43 to $12.10.
For 2040 the avg is $31.86 with a max of $53.84 and ROI of 215.5%; for 2050 the avg is $51.61 with a max of $95.44 and ROI of 411%. The sentiment is BULLISH.
Perrigo Company plc Community Discussion
0Share your Perrigo Company plc price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.